Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: Labrador who wrote (503)	12/31/1997 12:06:00 PM
From: MY OPINION	Read Replies (1) \| Respond to of 1837

bob, I can't tell you what too do! I was looking at this stock @ $3.75,watched it fall to $3.00 never bought,now i will look for an entry point on a pullback. Regards BIGS ps. HAPPY NEW YEAR EVERYONE!

To: Labrador who wrote (503)	12/31/1997 12:44:00 PM
From: art slott	Read Replies (1) \| Respond to of 1837

Definitely buying by money managers. If it brings in 10 mil. thats 25% growth over 96. They will get the ok for conjugated estrogen this year. I have no doubt now. FDA looked bad when they turned it down last time. They know it will be watched closely and will want to right the wrong. Art

To: Labrador who wrote (503)	1/1/1998 12:03:00 PM
From: Mama Bear	Read Replies (1) \| Respond to of 1837

bob, I'm mostly a short term trader, and recently the play with these FDA approvals is to go long (I bought DRMD at 3 1/2) when the approval is released, sell after some resistance (sold it way too soon), and look for a short entry. In just the last week I did this successfully with CEPH and RBOT. The buying strength in this stock over the last few days gives me pause on the short side. Especially when you couple the fact that the price had been as high as 12 1/4 this year and that this happened the last 2 days of the year. There should have been tax selling. At this point in time I'm doubtful that I will short, unless the run up continues. You might be better served to consider some Jan 5 puts (DUQMA) which are only asking 3/16. While it's not that long until expiry, if it sustains this price or even runs up you'll only lose the 3/16. If it turns around, there will be some premium built into the price. Oh, the fact that the puts are only asking 3/16 says to me that the options specialist are impressed with the upward movement. Hope this helps, Barb